06:46 AM EST, 02/04/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q4 adjusted earnings Tuesday of $12.07 per diluted share, up from $11.86 a year earlier.

Analysts polled by FactSet expected $11.35.

Revenue for the quarter ended Dec. 31 was $3.79 billion compared with $3.43 billion a year earlier.

Analysts surveyed by FactSet expected $3.74 billion.

Shares were up 5% in recent premarket activity.